Mei Chen is currently a Professor of Dermatology and Director of Research at the Keck
School of Medicine of the University of Southern California (USC). She earned a
Ph.D. in Cell Biology, Virology and Molecular Biology from the Albert Einstein
College of Medicine in New York. After postdoctoral training in Cell and
Developmental Biology at Memorial Sloan-Kettering Cancer Center and Cornell
University Medical College in New York, she joined the faculty of the Department of
Dermatology at Northwestern University Medical School in Chicago. Her research has focused
on elucidating the structure and function of type VII (anchoring fibril)
collagen and developing various therapeutic approaches including cell therapy,
small molecule-based drug therapy, protein therapy, and gene therapy for the treatment
of recessive dystrophic epidermolysis bullosa (RDEB).
Mei Chen is currently a Professor of Dermatology and Director of Research at the Keck
School of Medicine of the University of Southern California (USC). She earned a
Ph.D. in Cell Biology, Virology and Molecular Biology from the Albert Einstein
College of Medicine in New York. After postdoctoral training in Cell and
Developmental Biology at Memorial Sloan-Kettering Cancer Center and Cornell
University Medical College in New York, she joined the faculty of the Department of
Dermatology at Northwestern University Medical School in Chicago. Her research has focused
on elucidating the structure and function of type VII (anchoring fibril)
collagen and developing various therapeutic approaches including cell therapy,
small molecule-based drug therapy, protein therapy, and gene therapy for the treatment
of recessive dystrophic epidermolysis bullosa (RDEB).